Simply amazing the volume here today and lately but
today, even though 26,100 shares traded, ONLY 130 shares total traded in last 4:29 minutes. Now that is a low record for GTHP. No one is letting their shares go and that's a good thing. JMHO of course - GLTA Longs
This is probably a two to three year story now. The revelation that private trials will likely be conducted by early adopters in the US post-FDA approval (as are being done in international markets now) tells you share price likely isn't going anywhere right away. It will be a good trade around FDA but I'm afraid the long position will be dead money for awhile. GL.
It is not trials, but "customer evaluations lasting 6-12 weeks". Get the Facts. Carty said customers want to confirm they get the same results as in the clinical trials. $1-3M revenue in 2014 is co. guidance. 35 devices now in customer evaluations. I believe this stock will hit $1.50 in 2014.